TABLE 4.
Extragenital GC Test Visit Positivity Among Test Visits With Positive Urethral CT/Negative GC Test and Extragenital Testing Performed—STD Surveillance Network, 2015–2019
| Jurisdiction | Test Visits With Positive Urethral CT/Negative GC Test and Extragenital GC Testing Performed | Test Visits With Positive Urethral CT/Negative GC Test and Rectal GC Testing Performed | Test Visits With Positive Urethral CT/Negative GC Test and Pharyngeal GC Testing Performed | |||
|---|---|---|---|---|---|---|
|
|
|
|
|
|||
| Test Visits | Test Visits With Positive Extragenital GC Test | Test Visits | Test Visits With Positive Rectal GC Test | Test Visits | Test Visits With Positive Pharyngeal GC Test | |
|
|
|
|
|
|
|
|
| N | n (%) | N | n (%) | N | n (%) | |
|
| ||||||
| Total | 4566 | 596 | 3173 | 320 | 4432 | 393 |
| Weighted total positivity (95% CI) | 12.5 (10.9–14.1) | 9.4(7.4–11.4) | 8.8 (7.8–9.8) | |||
| Unweighted positivity by jurisdiction | ||||||
| Baltimore, MD | 88 | 8 (9.1) | 50 | 3 (6.0) | 85 | 5 (5.9) |
| Los Angeles County, CA* | 195 | 25 (12.8) | 132 | 13 (9.9) | 192 | 18 (9.4) |
| Miami, FL† | 68 | 11 (16.2) | 68 | 11 (16.2) | - | - |
| Boston, MA | 14 | 2 (14.3) | 12 | 2 (16.7) | 14 | 0 (0.0) |
| Multnomah County, OR | 266 | 37(13.9) | 199 | 22 (11.1) | 263 | 27 (10.3) |
| Minneapolis, MN | 564 | 53 (9.4) | 390 | 25 (6.4) | 558 | 39 (7.0) |
| New York City, NY | 1801 | 269 (14.9) | 1277 | 159 (12.5) | 1770 | 159(9.0) |
| Philadelphia. PA | 388 | 54(13.9) | 209 | 23 (11.0) | 383 | 46 (12.0) |
| San Francisco, CA | 821 | 95 (11.6) | 591 | 44 (7.5) | 811 | 67 (8.3) |
| Seattle, WA | 361 | 42(11.6) | 245 | 18 (7.4) | 356 | 32 (9.0) |
*
Data obtained in 2019 from participating clinics were not available for this analysis.
†
Participating clinics did not perform pharyngeal GC testing.